Induction of urinary bladder tumors in ACI-N rats by butyl (3-carboxypropyl) nitrosoamine, a major urinary metabolite of butyl- (4-hydroxybutyl) nitrosoamine
Hashimoto, Y.; Suzuki, E.; Okada, M.
Gan 63(5): 637-638
1972
ISSN/ISBN: 0016-450X PMID: 4645279 Document Number: 54282
Document emailed within 1 workday
Related Documents
Ito, N.; Matayoshi, K.; Arai, M.; Yoshioka, Y.; Kamamoto, Y. 1973: Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-n-(4-hydroxybutyl)nitrosoamine Gan 64(2): 151-159Okajima, E.; Hiramatsu, T.; Okamoto, M.; Kihoin, K.; Ijuin, M.; Hirao, Y.; Ohara, S.; Babaya, K.; Kubota, K.; Samma, S.; Okamura, K.; Kaneko, Y.; Horii, Y.; Moriya, A. 1982: Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 836-842
Nakanishi, K.; Hirose, M.; Ogiso, T.; Hasegawa, R.; Arai, M.; Ito, N. 1980: Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with n-butyl-n-(4-hydroxybutyl)nitrosamine Gan 71(4): 490-500
Sakata, T.; Shirai, T.; Fukushima, S.; Hasegawa, R.; Ito, N. 1984: Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats Gan 75(11): 950-956
Murase, T.; Kobayashi, O.; Aota, Y.; Mitsuta, H.; Koshikawa, T. 1983: Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor Hinyokika Kiyo. Acta Urologica Japonica 29(3): 303-310
Becci, P.J.; Thompson, H.J.; Grubbs, C.J.; Squire, R.A.; Brown, C.C.; Sporn, M.B.; Moon, R.C. 1978: Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine Cancer Research 38(12): 4463-4466
Toyoshima, K.; Ito, N.; Hiasa, Y.; Kamamoto, Y.; Makiura, S. 1971: Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: establishment of cell line, Nara Bladder Tumor Ii Journal of the National Cancer Institute 47(5): 979-985
Wei, M.; Wanibuchi, H.; Morimura, K.; Salim, E.I.; Moku, M.; Doi, K.; Mitsuhashi, M.; Masuda, C.; Shen, J.; Kinoshita, A.; Fukushima, S. 2004: Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice Anticancer Research 24(2b): 785-790
Ohtani, M.; Kakizoe, T.; Nishio, Y.; Sato, S.; Sugimura, T.; Fukushima, S.; Niijima, T. 1986: Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine Cancer Research 46(4 Part 2): 2001-2004
Kakizoe, T.; Kawachi, T.; Sugimura, T. 1979: Agglutination of bladder cells by concanavalin a during the early phase of treatment of rats with N-butyl-N-(4-hydroxybutyl)nitrosamine Cancer Research 39(9): 3353-3356
Suzuki, E.; Takeda, Y.; Mochizuki, M.; Hashimoto, Y.; Okada, M. 1981: Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat Gan 72(4): 539-546
Ito, N.; Hiasa, Y.; Kamamoto, Y.; Makiura, S.; Okajima, E. 1970: Effects of 2,5-di-O-acetyl-D-glucaro-(1,4) (6,3)-dilactone (SLA) on experimental bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Gan no Rinsho. Japan Journal of Cancer Clinics 16(10): 995-1001
Lijinsky, W.; Taylor, H.W. 1975: Induction of urinary bladder tumors in rats by administration nitrosomethyldodecylamine Cancer Research 35(4): 958-961
Lalwani, N.D.; Reddy, M.K.; Qureshi, S.A.; Moehle, C.M.; Hayashi, H.; Reddy, J.K. 1983: Noninhibitory effect of antioxidants ethoxyquin, 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on hepatic peroxisome proliferation and peroxisomal fatty acid beta-oxidation induced by a hypolipidemic agent in rats Cancer Research 43(4): 1680-1687
Han, G.Z.; Seshadri, R. 1995: Simultaneous determination of N, N-di(n-butyl)doxorubicin-14-valerate and its 8 urinary metabolites by HPLC Zhongguo Yao Li Xue Bao 16(2): 102-107
Dimmock, J.R.; Semple, H.A.; John, S.; Beazely, M.A.; Abrams, G.D. 1999: Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy)benzaldehyde semicarbazone after oral dosing to rats Die Pharmazie 54(4): 260-262
So, B.T.; Wynder, E.L. 1972: Induction of hamster tumors of the urinary bladder by 3,2'-dimethyl-4-aminobiphenyl Journal of the National Cancer Institute 48(6): 1733-1738
Rice, J.R.; Spry, L.A.; Zenser, T.V.; Davis, B.B. 1988: Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats Cancer Research 48(2): 304-309
Maickel, R.P.; McFadden, D.P. 1979: Acute toxicology of butyl nitrites and butyl alcohols Research Communications in Chemical Pathology and Pharmacology 26(1): 75-83
Schmähl, D.; Krüger, F.W. 1972: Lack of a syncarcinogenic effect of cyclamate in inducing bladder neoplasms by butyl-butanol-nitrosamine in rats Arzneimittel-Forschung 22(6): 999-1000